The imbalance in the host-parasite equilibrium in successfully osseointegrated endosteal implants may cause inflammatory changes leading to mucositis or peri-implantitis, an irreversible lesion involving the bone-implant interface (I). Peri-implantitis is regarded as a site-specific infection with microbial features and host peri-implant tissue response similar to chronic periodontitis, but characterized by a faster tissue destruction. A further condition associated with implant failure is absence of osseointegration (2) which shows a dense fibrous connective tissue and granuloma tissue formation with absent or scarce inflammatory cells (ICs) around the oral implant. In peri-impantitis, many mononuclear and polymorphonuclear cells (PMN) are found in the epithelium, and mononuclear and plasma cells infiltrate the connective tissue (2) . Progressing deeper into the connective tissues, collagen fibers and fibroblasts are increasingly replaced by ICs, including Mast Cells (MCs). MCs are motile granule-containing cells that originate from bone marrow pluripotential haematopoietic cells, circulate in blood and extravasate in tissues where they acquire their mature phenotype locally in the peripheral mucosa (including all tissues of the oral cavity, such as dental pulp), in connective tissue microenvironments rich in fibroblasts and in other tissues where they ultimately reside. MCs are phagocytic, are able to present antigens as effectively as macrophages, and play an important role in mucosal inflammation, host defense and tissue repair (3) .
We herein review the biology and function of MCs, with particular focus on their role in dental implant failure due to the absence ofosseointegration or peri-implantitis.
MAST CELLS
The first description of the cells thereafter named "Mastzellen" (or "well fed cells") was provided by Paul Ehrlich, but Von Recklinghausen was probably the first who observed these cells (4) . Mature MCs ordinarily do not circulate in the blood but are present in the entire body, especially in the dermis or in the superficial lamina propria just below the epithelium; they can be divided according to their serine protease content into two subpopulations: one containing both tryptase and chymase and more stores of histamine and tumor necrosis factor (TNF) (5); the other, containing only tryptase, known as mucosal phenotypes (6) .
A striking increase in the number of MCs has been found in inflamed gingiva and human tissues affected by chronic inflammation (5) . Due to an extremely broad spectrum of potential mechanisms, MCs influence the development, extent or duration of inflammatory and other biological responses, such as extracellular matrix degradation, angiogenesis and innate and adaptive immune responses in periimplant disease, as well as periodontitis (7) .
MCs have been shown to exert beneficial functions as in innate and adaptive immune responses against foreign molecules and infectious agents such as parasitic infestations (4) . Their ability to undergo phagocytosis (Fig. I) decreases with increased maturity. After antigen uptake and processing, a direct contact of MCs with lymphocytes is a fundamental requirement for antigen presentation and the major prerequisite for these interactions is the presence of major histocompatibility (MHC) complex and the T cell receptor (TCR) on CD4+ or CD8+ lymphocytes. MCs express a number of receptors (Fig. I) which allow them to interact with T and B lymphocytes. MCs both attract lymphocytes and migrate towards these cells. lntegrins enable them to interact with endothelial cells (ECs) and with connective tissue components, such as fibronectin, laminin and collagens I, II and IV (8) . They have a potential role in atopy on the basis of effects on allergen presentation and IgE synthesis, and regulate components of the immune system, contributing to the development of non-specific as well as specific inflammatory responses (9) .
MCs can be activated by a variety of endogenous and exogenous peptides, cytokines and other inflammatory mediators. Upon appropriate activation, they can release a diverse array of potent biologically active products (Fig. 2 ) which can be classified as: (i) preformed mediators stored in the cells' prominent cytoplasmic granules, including histamine, proteoglycans, and proteases such as chymase, tryptase and carboxypeptidase A; (ii) de novo synthesized lipid mediators, e.g., metabolites of arachidonic acid via either the cyclooxygenase (e.g., PGD2) or lipoxygenase (e.g., LTC4) pathways; (iii) a large number of cytokines ("piecemeal degranulation"), chemokines and growth factors (4).
MCs IN PERI-IMPLANT INFLAMMATORY CONDITIONS

Peri-implant host response
Peri-implantitis seems to be related to the periimplant environment at the soft tissue/implant interface, to patient-related factors (smoking, systemic diseases, plaque control) and to hostparasite equilibrium. Marked differences were observed in the composition ofsupra-and subgingival biofilm between healthy and diseased implants. The microbiota associated with peri-implantitis was comprised of many periodontal pathogenic bacterial species, including the supragingival biofilm resembling that found in chronic periodontitis (predominantly anaerobic Gram-negative bacilli, in particular Porphyromonas gingivalis and Prevotella intermedia, and cocci, such as Veillonella spp. and spirochaetes including Treponema denticola) (10 lipopolysaccharides originating from Gram-negative bacteria or lipoteichoic acid present in Grampositive bacteria, and other pathogenic factors cause inflammatory response which is characterized by infiltration of the tissues by neutrophils, macrophages and lymphocytes, and the generation of high concentrations locally of cytokines, eicosanoids and other tissue-destructive mediators such as matrix metalloproteinases (MMPs) (11) .
The inflammatory and immune responses initiated by periodonto-pathogens are thought to protect the host against infection. Basal or constitutive expression of innate effector molecules (prostanoids, cytokines, etc) and receptors facilitates molecular recognition by dialogue with bacteria and bacterial products within the gingival tissues. Disruption of any of these factors can lead to peri-implant disease.
MCs are important in the first line of defense against infection, when the host tries to prevent microorganisms colonizing the peri-implant tissue. MCs reside close to 'l-cells, can undergo phagocytosis and process bacterial antigens, and minate adaptive immune responses by presenting antigens to T-cells and are a source of Th 1-and Th2-inducing cytokines (12) . An effective response is triggered by host recognition of patterns of association between pathogen molecules and cell surface receptors on host cells and this association is an important mechanism in the activation of innate immunity. As in periodontitis, MCs produce a large number of biologically active substances. When there is a permanent association among pathogenic molecules, host tissue-destruction mediators and receptors, a chronic inflammatory process develops in peri-implant tissues. As in periodontal tissue (13) , the persistence of a local chronic host response may alter the protective roles of IC and produce deleterious effects to soft and hard peri-implant tissues, and MCs also seem to be involved in these process.
Hence, MCs activation, through promoting proor anti-inflammatory events and patho-physiological changes depending on context, could play an important role in many inflammatory responses and :~~~~:
.,-----" 
diseases (4) and in peri-implantitis,
The role ofhistamine
Histamine is a III Da, multifunctional, basic amine synthesized by histidine decarboxylase in the Golgi apparatus and stored in Me granules.
Once released, methylation and oxidation rapidly catabolize histamine (\ 4). It contributes to a faster recruitment of inflammatory cells, increases albumin leakage in post-capillary venules and acts on capillary permeability at the venular level via Histamine Receptor-I (H IR). It also up-regulates the expression of P-selectin on the endothelial cell surface, thereby promoting the adhesion of platelets, enhancing the "rolling" of passing phagocytes and supporting transient leukocyte adhesion to endothelial cells (14) . Histamine is important in facilitating the recruitment of IC to biomaterial implants triggering both edematous and hyperemic responses and in the worsening of inflammation (15) . Adsorption and later "denaturation" of fibrinogen is the main factor in triggering biomaterial-mediated inflammatory responses in both mice and humans (16) . Histamine induces IL-8 production from gingival fibroblasts via HI R, and synergistically augments the inflammatory response by amplification of the mitogen-activated protein kinases and Nuclear Factor-x B (NF-KB), through HI R-linked phospholipase C (17) .
Lipopolysaccharides and lipoteichoic acid increase the histamine response in human gingival fibroblasts via promotion of HI R expression and of intra-cellular calcium mobilization. Histamine amplifies Toll-like Receptor-2 and -4 sensitivity, ciclo-oxygenase-2 expression and prostaglandin-2 synthesis in gingival fibroblasts (18) . MC-deficient mice and mice treated with HI R antagonists had greatly reduced acute inflammatory responses to implanted biomaterials (16) . Treatment with a combination of H lIH2R antagonists diminishes initial phagocyte recruitment and accumulation by more than 80% on implant surfaces (15) , probably by suppression of implant-mediated hyperemia and loosening of the endothelial barrier. The reduced fibrinogen surface interactions should enhance biocompatibility. The administration of HI R antagonists shortly before and after the placement of implants in humans may reduce the phagocytemediated foreign body responses and later reactions, such as fibrotic capsule or IC formation, improving implant functionality and longevity (16). The reduction of histamine level, through the inhibition of histidine decarboxylase activity (19) or HI R antagonists, could offer the basis for novel strategies to increase osseointegration or prevent and treat periimplant inflammatory diseases.
The role ofcytokines and chemokines
Cytokines play an important role in the soft (20) . MC-TNF seems to be linked with the initiation of inflammation and the development of chronic inflammation in the oral mucosa (7) and plays a role in periodontal inflammation and host defense. MCs constitutively synthesize and release a substantial amount of TNF-a without obvious stimulation (21) . MC-TNF-a production can be up-or downregulated by many factors (Fig. I) and act differently on macrophages, T and B cells.
MCs produce several chemokines like CCL2 (MCP-I), CCL3 (MIP-Ia, b) and CCL5 (RANTES), a large family of small structurally related heparinbinding proteins binding to receptors CCR2, CCR I and CCR5, respectively. Chemokines are soluble mediators that influence recruitment, localization and activation of IC and also contribute to the regulation of epithelialization, tissue remodeling, angiogenesis integrating inflammatory events and reparative processes. CCL5 can also act on osteoblasts, resulting in chemotaxis and promoting cell survival (22) .
There are multiple overlapping and complex functional links between cytokines with regulatory control exerted at a number of levels and involving numerous cell types (both immune cells and resident cells in the periodontium). Cytokines appear to interact functionally in networks in the periodontium and integrate aspects of innate and adaptive immunity. They have broad molecular interactions that are relevant to many aspects of immunity and inflammation. As in periodontal pathogenesis, cytokines have wide ranging and overlapping functions, as would be expected in any tissue compartment exposed to a chronic bacterial challenge and in which there is persistent chronic inflammation. The balance between pro-and antiinflammatory cytokines and regulation of their receptors and signalling pathways determines the extent of peri-implant tissue destruction (23) .
MC activation by lipopolysaccharides or other bacterical products, biomaterial particles and MC mediators themselves (such as histamine), induces an immediate cytokine cascade activation and several immunopathological changes, which could lead to peri-implant host defense or soft and hard tissue destruction (24) .
Innate immune system cells and lymphocytes both primarily rely on cytokines for mediating their effector and regulatory functions. However, cytokine responses by the innate immune system are quite different from those of lymphocytes.
Upon initial exposure to an antigen, a small number of naive T-cells proliferate. This clonal activation is antigen-specific and occurs in the primary lymphoid tissues. While some activated cells become effector cells by releasing soluble factors or cytokines, others remain in the circulation as memory T cells. Memory T cells are capable of responding to subsequent antigen exposure and their cytokine production shows long-term commitment. Secondary responses are more efficient because of the presence of memory cells.
The cytokine microenvironment during the primary Ag-naive T-cell interaction defines which cytokine the T memory cells will express (25) . While naive T cells do not produce cytokines but learn to express them via an instructed differentiation process, MCs can produce IL-4 during the primary antigen encounter and promote the generation of IL-4-producing memory T cells (Th2 cells). Therefore, the MC-IL-4 production represents a type of interaction between the innate and the adaptive immune system that can contribute to the outcome of host defense and immune pathology. In fact, MCs can contribute to suppressing inflammation and immune responses and significantly to the cytokine network of wound repair via MC-IL-4 and stimulation of fibroblasts (26) . Moreover, MC-IL-25 production may regulate Th2 memory cells which enhance expansion and Th2 polarization and sustain their activation status, thereby resulting in an amplified Th2 immune response (27) .
MC and T-lymphocyte interactions, as in several periodontal diseases, drive peri-implant inflammatory response by a high degree of redundancy because of the plethora of cytokines secreted or synthesized could promote IC chemoattraction and its chronicity in the soft and bone environment, contributing to the disruption of peri-implant tissue homeostasis (28) (29) .
CD40 ligand (CD40L), which is displayed on MCs, is highly expressed in inflamed tissue (30) and functionally interacts with CD40, a member of the TNF-a receptor family constitutively expressed in periodontal and gingival fibroblasts. Through CD40/ CD40L interaction, MCs and gingival fibroblasts participate in the pathogenesis of peri-implantitis by up-regulating both vascularity and matrix breakdown, promoting migration/maintenance of Ie. This interaction can also stimulate and up-regulate fibroblast activation and synthesis of the proinflammatory cytokine IL-6 or IL-8 (31). Moreover, through CD40L, MCs are involved in the regulation of immune responses promoting immunoglobulin class switching to antibody isotypes supported by the T helper type 2 (Th2) phenotype (9, 29) .
MC-IL-4 at sites of inflammation may playa role in T-cell differentiation toward the Th2 phenotype and with IL-3 and IL-9 can regulate the changes in MC number, tissue distribution and/or phenotypic characteristics (8) .
MC-TGF-~I, a potent chemoattractant for leukocytes, seems to be involved in the formation of the IC infiltrate and in the regulation ofMC function (24) .
Acute release of TNF-a by MCs appears to be critically important in recruiting neutrophils, by induction of endothelial expression of E-selectin (CD62E, ELAM-I) and T-Iymphocytes (21). MC-TNF-a can arrest the growth of epithelial cells and could increase the levels of IL-6, IL-8, MCPI in peri-implant fibroblasts and MC-IL8 (29) . TNF-a and IL-I~are able to induce MC-IL-13 and -MCP-I and MC-IL-5 promote MC-TNF, -IL-13 and -MIP-I a secretion. The MC inflammatory cytokine synthesis stimulated by IL-I~may be partly mediated by IL-I receptor-binding (31) . Furthermore, TNF-a augments cytotoxic responses and induces CCL-5-Tlymphocytes which promote MC-degranulation and survival and development of chronic inflammation through CCRI on MCs (30) .
Chronic synthesis and release of MC-IL-4, after E-selectin and P-selectin suppression, and induction of vascular cell adhesion molecule I (VCAM-I) and CD I06 (22) promote a transition from acute to chronic inflammation and bind strongly to lymphocytes, weakly to monocytes but not to granulocytes (30) . Higher levels of IL-4 were found in progressive periodontal lesion with an increase in inflammation and in the numbers of IgG4+ B-cells and plasma cells in comparison with IgG2+ cells (12) .
MC-chemokines may contribute to the bone remodeling process and to enhancing the chronic inflammatory process leading to bone resorption around the implant (22) . Chemokine production by osteoblasts can be induced by microbial products, inflammatory mediators, dentin proteins, and even by particulate wear debris (32) . CCR1, expressed in precursors of mature osteoclasts, via CCL-3/-5 binding, stimulates osteoclast precursor chemotaxis and differentiation (32). CCL3, described as an osteoclast differentiation factor, induces adhesion of osteoclasts to primary osteoblast regulation and interaction (33) . CCL2 is also associated with osteoclast chemotaxis and differentiation, and mediates the recruitment of monocytes in osseous inflammation, bone remodeling, and tooth eruption (33) . In addition, both CCL3 and CCL2 are involved in phagocyte chemotaxis toward the implant surface (4) . Neutralization of chemokines may reduce IC accumulation and may protect against allergy, toxic shock syndrome and inflammatory diseases (34) .
IL-I a, IL-I p, IL-6, IL-ll TNF-a and TGF-p are also produced by dental mesenchymal cells, fibroblasts and inflammatory cells in pathological conditions, especially in periodontal disease, which lead to tissue inflammation, bone resorption and ultimately tooth loss in the bone microenvironment surrounding teeth, preventing bone resorption in periodontal structures (35) . Osteoprotegerin (OPG) secreted by dental mesenchymeal cells may play an important role in a paracrine manner as a decoy receptor binding to receptor activator of nuclear factor (NF)-KB ligand (RANKL) on osteoblasts/stromal cells. In addition, it may improve osseointegration of implants by inhibiting IL-l a.
The role ofMMPs and serine proteases
MCs also constitute a source of important proteolytic enzymes with the potential to mediate breakdown of extracellular matrix. Tryptase, a trypsin-like proteinase produced and stored almost exclusively in MCs up to 35 pg per cell, could cleave fibrinogen, activate latent collagenase, and have numerous other functional activities (Fig. 3) (36) . It activates Proteinase-activated receptor (PAR)-2 (37), a G-protein-coupled, seven-transmembrane-domain receptor that seems to have a pivotal role in the pathogenesis of periodontal disease. Chymase may activate latent IL-l p, MMP-3 and pro-collagenase (pro-MMP-l) and indirectly progelatinase B (MMP-9, Fig. 3 ) (38) . Therefore, chymase participates in extracellular matrix remodeling by modulating collagenase activity and fibroblast function and in interrupting axonreflex-mediated neurogenic inflammation by degrading neuropeptides. In addition, it modulates oral MC-histamine (39) .
MMPs are secreted in latent and inactive proenzyme forms, with plasmin and other MMPs as likely activators, and play important roles in degradation of the extracellular matrix, toward IC in periodontal and peri-implant disease. MMP activity is further modulated by the tissue inhibitors of MPs (TIMP-l, -2 and -3), which partly control and stabilize MMPs (34) .
Gingival MCs are the foremost producers of MMP-l and -8, while about half express MMP-2 and TIMP-l. Only a few cells express TIMP-2 (40). A higher post-implantation collagenase activity level, due to the increase in MMP-l and -8, is seen at 1 week than at weeks 2, 4, and 12. Furthermore, peri-implantitis shows similar inflammatory lesions regarding MMP-l and -8 isoenzymes species (PMN and fibroblast-type), matrilysin-l/MMP-7 and collagenase activities, significantly higher collagenase-2 (MMP-8) levels and activity (41) , and lower TIMP-l/MMP-I +MMP-8 ratio and MMP-7 (42) . In addition, the overproduction of TIMP-l in the wound area after implantation could, to some extent, inhibit excessive tissue destruction and degradation of the neo-matrix in wound repair due to MMPs (42) .
MC-chymases seem to have a pro-inflammatory and proangiogenetic effect in granuloma formation due to their ability to cleave angiotensin I into its active fragment, angiotensin II, by increasing its local production, which upregulates VEGFmRNA (38) , and through the extracellular matrix degradation that occurs during angiogenesis.
MC peptidases (primarily chymase and/or cathepsin G rather than tryptases) cleave a variety of cytokines produced by cultured human MCs, including IL-5, -6, -13 and TNF-a, by limiting inflammatory responses in vivo (39) . However, the net effect of cytokine inactivation by MC peptidases can be negative or even lethal (43) .
MC-MMPs, -tryptase and -chymase embody similar dichotomies of benefit versus detriment, control versus spread of inflammation, and tissue defense versus destruction (34) . Their disregulation could participate to connective tissue breakdown, granuloma-associated angiogenesis and related bone resorption in peri-implantitis (44) .
Tryptase may be a promising target for therapeutic intervention (36) . A novel class of antiinflammatory drugs, like the proteinase inhibitors, significantly inhibited tryptase and chymase-induced nucleated cell accumulation in vivo (36) . Ketotifen (45) seems to be a potential therapeutic agent against peri-implantitis as it inhibits not only the release of preformed mediators from MCs but also granuloma formation, bone resorption and related angiogenesis induced via chymase mechanisms in collaboration with other mediators (46) , thus it may be worth considering its possible use in peri-implantitis treatment.
Also Zinc-Chelation by Ellagic acid, a dietary polyphenolic compound, showed anti-angiogenic effects by inhibiting MMP-2 activity, tube formation and cell migration of vascular endothelial cells and could be used for peri-implantitis treatment (47) .
CONCLUSIONS
MCs are key cell types actively involved in the pathogenesis of periodontal and peri-implant inflammation. The ability of the MCs to generate individual populations that differ in functional properties, mediator content and/or other aspects of phenotype probably confers on mast cells a potentially complex functional repertoire. The cell can be activated and their specific functions can be expressed based on the requirements of the individual physiological, immunological, inflammatory, or other biological responses in which these cells participate. In this article, we review some basic principles of mast cell biology and functions involved in inflammatory peri-implant response to promote absence of osseointegration or peri-implantitis. On implant surfaces, adsorption and later denaturation of fibrinogen or others stimuli could involve MCs activation and degranulation. Histamine could trigger a phagocyte recruitment and accumulation on implant surfaces. MCcytokines increase inflammatory peri-implant response promoting infiltration of IC and tissue destruction. The MMPs, and tryptase and chymase MC production could contribute to connective tissue breakdown, granuloma-associated angiogenesis and related bone resorption in peri-implantitis. Further studies are need to clarify the role of MCs in peri-implant inflammatory condition. However, on the basis of the suggestions herein presented and therapeutic implications of the findings we should build up strategies directed toward the possible use of drugs to inhibit and/or influence MC activation and/or secretion (e.g. HI R antagonists, like Terfenadine, Cetirizine, Rupatadine, or Serine proteases inhibitors, such as Ketotifin or Zincchelation compound) to increase osseointegration, and to prevent and treat peri-implant disease.
